HIV testing strategies to reach key populations

Testing for HIV is an essential first step towards linking people with effective HIV prevention and treatment programming. People who know their HIV status can make decisions about their lives that can help prevent HIV acquisition or make it more likely they get treatment if they test positive. Studies have shown that the sooner people know their HIV status and get treatment after testing positive for HIV, the longer they can remain healthy. 

Despite progress with HIV testing technology and uptake, many individuals vulnerable to HIV acquisition do not know their HIV status, in particular, people in key populations that face stigma and discrimination.  

The IAS recognizes key populations as gay men and other men who have sex with men, people who inject drugs, prisoners and other incarcerated people, sex workers and their clients, and trans people. These populations are more likely to be exposed to HIV and face violence, stigma, discrimination and laws that restrict their movement or access to services. 

This first event will review current knowledge on key populations and HIV testing, barriers to HIV testing and outreach strategies with the aim of identifying areas where the industry can contribute to improving testing for HIV. 

This session is the first out of three in the Reaching the 95-95-95 targets: The importance of multi-stakeholder collaboration series. Watch session 2 here and session 3 here

18 April 2023
Download meeting report
Chair

Helen McDowell

Head of Government Affairs & Public Health

ViiV Healthcare

Speakers

Cheryl Johnson

WHO

Testing strategies for vulnerable populations

Omar Syarif

GNP+

Community perspective: Current barriers to HIV testing

Rena Janamnuaysook

Program Manager for Implementation Science

Institute of HIV Research and Innovation (IHRI)

HIV testing among transgender women attending the Tangerine Community Health Clinic, Bangkok, Thailand
Duncan Blair

Duncan Blair

Vice President of Global Health Initiatives

Abbott

Challenges of registering new products
Panelists

Helen McDowell

Head of Government Affairs & Public Health

ViiV Healthcare

Antons Mozalevskis

Technical Officer for Key Populations

WHO

Jennifer Sherwood

Jennifer Sherwood

Public Policy Manager

amfAR, The Foundation for AIDS Research.

Tafadzwa Dzinamarira

Interim Country Director

ICAP at Columbia University, Zimbabwe

Samuel (Tony) Boova

Principal for Medical & Scientific Affairs and Global Market Access

Beckman Coulter Life Sciences

Ombeni Mwerinde

Unitaid